Tiffaney L. Vincent

2.1k total citations
20 papers, 954 citations indexed

About

Tiffaney L. Vincent is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Immunology. According to data from OpenAlex, Tiffaney L. Vincent has authored 20 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 11 papers in Hematology and 6 papers in Immunology. Recurrent topics in Tiffaney L. Vincent's work include Acute Lymphoblastic Leukemia research (14 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Acute Myeloid Leukemia Research (5 papers). Tiffaney L. Vincent is often cited by papers focused on Acute Lymphoblastic Leukemia research (14 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Acute Myeloid Leukemia Research (5 papers). Tiffaney L. Vincent collaborates with scholars based in United States, Canada and Belgium. Tiffaney L. Vincent's co-authors include David T. Teachey, Stephan A. Grupp, Stephen P. Hunger, Sarah K. Tasian, Mignon L. Loh, Alix E. Seif, Shannon L. Maude, Charles G. Mullighan, Junior Hall and Cheryl L. Willman and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer Research.

In The Last Decade

Tiffaney L. Vincent

19 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tiffaney L. Vincent United States 11 444 441 221 219 197 20 954
Toru Sakura Japan 19 313 0.7× 751 1.7× 195 0.9× 178 0.8× 54 0.3× 70 960
Monika Csóka Hungary 15 183 0.4× 82 0.2× 339 1.5× 266 1.2× 155 0.8× 57 876
Anna Mestice Italy 17 176 0.4× 554 1.3× 143 0.6× 275 1.3× 60 0.3× 39 870
Iris H.I.M. Hollink Netherlands 19 313 0.7× 848 1.9× 109 0.5× 684 3.1× 83 0.4× 35 1.2k
Cristina Bugarin Italy 13 161 0.4× 273 0.6× 142 0.6× 153 0.7× 37 0.2× 26 605
ER van Wering Netherlands 12 649 1.5× 719 1.6× 123 0.6× 317 1.4× 47 0.2× 16 1.1k
Markéta Kalinová Czechia 13 296 0.7× 232 0.5× 121 0.5× 300 1.4× 71 0.4× 38 581
Susana Vives Spain 10 231 0.5× 533 1.2× 209 0.9× 272 1.2× 41 0.2× 37 791
Paulo Lúcio Portugal 13 308 0.7× 469 1.1× 160 0.7× 255 1.2× 29 0.1× 30 854
T. Karakas Germany 11 200 0.5× 346 0.8× 220 1.0× 478 2.2× 70 0.4× 15 858

Countries citing papers authored by Tiffaney L. Vincent

Since Specialization
Citations

This map shows the geographic impact of Tiffaney L. Vincent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffaney L. Vincent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffaney L. Vincent more than expected).

Fields of papers citing papers by Tiffaney L. Vincent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiffaney L. Vincent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffaney L. Vincent. The network helps show where Tiffaney L. Vincent may publish in the future.

Co-authorship network of co-authors of Tiffaney L. Vincent

This figure shows the co-authorship network connecting the top 25 collaborators of Tiffaney L. Vincent. A scholar is included among the top collaborators of Tiffaney L. Vincent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffaney L. Vincent. Tiffaney L. Vincent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chandrasekaran, Prashant, Tiffaney L. Vincent, Felix R. De Bie, et al.. (2024). Chronic Hypoxia in an EXTrauterine Environment for Neonatal Development Impairs Lung Development. American Journal of Respiratory Cell and Molecular Biology. 72(4). 441–452. 2 indexed citations
2.
Saygin, Caner, Girish Venkataraman, Vijayalakshmi Ananthanarayanan, et al.. (2023). Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia. Clinical Cancer Research. 29(16). 3151–3161. 10 indexed citations
3.
Diorio, Caroline, Kimberly Veliz, Olga Shestova, et al.. (2023). CD38 as a pan-hematologic target for chimeric antigen receptor T cells. Blood Advances. 7(16). 4418–4430. 33 indexed citations
4.
Meyer, Lauren K., Cristina Delgado-Martín, Phillip P. Sharp, et al.. (2022). Inhibition of the Sec61 translocon overcomes cytokine‐induced glucocorticoid resistance in T‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 198(1). 137–141. 6 indexed citations
5.
Bride, Karen L., Hai Hu, Anastasia N. Tikhonova, et al.. (2021). Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia. Haematologica. 107(8). 1746–1757. 25 indexed citations
6.
Chen, Changya, Jason Xu, Tiffaney L. Vincent, et al.. (2021). Treatment Resistance in ETP-ALL Is Associated with Progenitor-like Arrest State. Blood. 138(Supplement 1). 618–618.
7.
Meyer, Lauren K., Benjamin J. Huang, Cristina Delgado-Martín, et al.. (2019). Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes. Journal of Clinical Investigation. 130(2). 863–876. 35 indexed citations
8.
Evensen, Nikki A., Julia Meyer, David J. Araten, et al.. (2018). MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia. Haematologica. 103(5). 830–839. 28 indexed citations
9.
Dolai, Sibasish, Alissa K. Robbins, Ling Zhong, et al.. (2016). Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia. Cancer Research. 76(9). 2766–2777. 12 indexed citations
10.
Tasian, Sarah K., David T. Teachey, Yong Li, et al.. (2016). Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia. Blood. 129(2). 177–187. 110 indexed citations
11.
Frank, David B., Tien Peng, Jarod A. Zepp, et al.. (2016). Emergence of a Wave of Wnt Signaling that Regulates Lung Alveologenesis by Controlling Epithelial Self-Renewal and Differentiation. Cell Reports. 17(9). 2312–2325. 193 indexed citations
12.
Tasian, Sarah K., Yong Li, Feng Shen, et al.. (2015). Potent Efficacy of Combined PI3K/mTOR and JAK or SRC/ABL Inhibition in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia. Blood. 126(23). 798–798. 2 indexed citations
13.
Bride, Karen L., Tiffaney L. Vincent, Kim Smith‐Whitley, et al.. (2015). Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood. 127(1). 17–28. 132 indexed citations
14.
Maude, Shannon L., Sibasish Dolai, Cristina Delgado-Martín, et al.. (2015). Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia. Blood. 125(11). 1759–1767. 158 indexed citations
15.
Tasian, Sarah K., Yong Li, Theresa Ryan, et al.. (2013). In Vivo Efficacy of PI3K Pathway Signaling Inhibition for Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia. Blood. 122(21). 2672–2672. 5 indexed citations
16.
Teachey, David T., Tiffaney L. Vincent, Kim Smith‐Whitley, et al.. (2013). Targeting mTOR Signaling Leads To Complete and Durable Responses In Children With Multi-Lineage Autoimmune Cytopenias, Including ALPS, SLE, Evans and CVID. Blood. 122(21). 330–330. 1 indexed citations
17.
Maude, Shannon L., Sarah K. Tasian, & Tiffaney L. Vincent. (2012). 2012 ASPHO Abstracts. Pediatric Blood & Cancer. 58(7). 1014–1097. 2 indexed citations
18.
Maude, Shannon L., Sarah K. Tasian, Tiffaney L. Vincent, et al.. (2012). Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia. Blood. 120(17). 3510–3518. 196 indexed citations
19.
Maude, Shannon L., Sarah K. Tasian, Tiffaney L. Vincent, et al.. (2011). Targeting mTOR and JAK2 in Xenograft Models of CRLF2-Overexpressing Acute Lymphoblastic Leukemia (ALL). Blood. 118(21). 249–249. 3 indexed citations
20.
Teachey, David T., Tiffaney L. Vincent, Cheryl L. Willman, et al.. (2010). Targeting mTOR Signaling Is An Effective Treatment Strategy for IKAROS and JAK Kinase Mutated Acute Lymphoblastic Leukemia. Blood. 116(21). 3251–3251. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toru Sakura Breakdown of academic impact, for papers by Monika Csóka Breakdown of academic impact, for papers by Anna Mestice Breakdown of academic impact, for papers by Iris H.I.M. Hollink Breakdown of academic impact, for papers by Cristina Bugarin Breakdown of academic impact, for papers by ER van Wering Breakdown of academic impact, for papers by Markéta Kalinová Breakdown of academic impact, for papers by Susana Vives Breakdown of academic impact, for papers by Paulo Lúcio Breakdown of academic impact, for papers by T. Karakas
Rankless by CCL
2026